U.S. pharma big copyright scrapped two experimental weight loss capsules very last yr—a at the time-day-to-day capsule, lotiglipron, because of elevated liver enzymes and a 2 times-every day capsule, danuglipron, due to potent side effects—but CEO Albert Bourla has stated the company is determined to “Perform and get” from the weight proble